Skip to main content

Table 4 Five-year relative survival rates according to the stage of diagnosis

From: Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years

Variables N Deaths 5-year relative survival rates (95% CI)
Age    
FIGO I-II    
< 50 73 20 80.69 (69.09-88.29)
50-70 111 40 79.50 (69.94-86.32)
>=70 61 42 59.88 (43.12-73.15)
FIGO III-IV    
< 50 78 59 35.83 (25.11-46.65)
50-70 231 192 26.31 (20.59-32.36)
> = 70 155 137 20.70 (13.91-28.44)
Histologic type    
FIGO I-II    
Serous 101 44 73.38 (61.98-81.85)
Mucinous-endometroîd 78 31 74.94 (62.74-83.65)
Other epithelials 34 19 65.82 (45.99-79.83)
Non epithelials 32 8 93.79 (67.65-98.95)
FIGO III-IV    
Serous 315 255 31.11 (25.68-36.68)
Mucinous-endometroîd 82 71 21.36 (12.94-31.19)
Other epithelials 49 48 6.21 (1.41-16.34)
Non epithelials * * *
Period of diagnosis   
FIGO I-II    
1982-1989 84 39 73.44 (61.20-82.35)
1990-1997 84 38 75.40 (63.00-84.15)
1998-2005 77 25 80.83 (67.98-88.93)
FIGO III-IV    
1982-1989 122 110 19.46 (12.53-27.52)
1990-1997 160 145 20.31 (14.24-27.15)
1998-2005 182 133 36.24 (28.68-43.84)
Place of residence    
FIGO I-II    
Urban 143 59 75.02 (65.89-82.03)
rural 102 43 77.66 (67.08-85.20)
FIGO III-IV    
Urban 248 203 28.54 (22.62-34.71)
rural 215 184 23.38 (17.63-29.63)